<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased levels of C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, a cleavage product of proinsulin, circulate in patients with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and early type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, a high-risk population for the development of a diffuse and extensive pattern of <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The present study examined the effect of C-<z:chebi fb="7" ids="16670">peptide</z:chebi> on CD4(+) lymphocyte migration, an important process in early atherogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>C-<z:chebi fb="7" ids="16670">peptide</z:chebi> stimulated CD4(+) cell chemotaxis in a concentration-dependent manner </plain></SENT>
<SENT sid="3" pm="."><plain>This process involves <z:e sem="disease" ids="C0043167" disease_type="Disease or Syndrome" abbrv="">pertussis</z:e> toxin-sensitive G-proteins as well as activation of <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> 3-kinase (PI 3-K) </plain></SENT>
<SENT sid="4" pm="."><plain>Biochemical analysis showed that C-<z:chebi fb="7" ids="16670">peptide</z:chebi> induced recruitment of PI 3-K to the cell membrane as well as PI 3-K activation in human CD4(+) cells </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> peroxisome proliferator-activated receptor gamma-activating <z:chebi fb="0" ids="50864">thiazolidinediones</z:chebi> inhibited C-<z:chebi fb="7" ids="16670">peptide</z:chebi>-induced CD4(+) cell chemotaxis as well as PI 3-Kgamma activation </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, immunofluorescence staining of thoracic artery specimen of diabetic patients showed intimal CD4(+) cells in areas with C-<z:chebi fb="7" ids="16670">peptide</z:chebi> deposition </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, C-<z:chebi fb="7" ids="16670">peptide</z:chebi> might deposit in the arterial intima in diabetic patients during early atherogenesis and subsequently attract CD4(+) cells to migrate into the vessel wall </plain></SENT>
</text></document>